Updated October 10, 2018 This content is archived.
Research by Jonathan F. Lovell, PhD, associate professor of biomedical engineering, a joint program between the School of Engineering and Applied Sciences and the Jacobs School of Medicine and Biomedical Sciences, could boost the efficacy of malarial transmission-blocking vaccines to help reduce the spread of the disease that kills more than 400,000 people annually. “Malaria is a huge global problem. This approach — using a transmission-blocking vaccine — could be part of a suite of tools that we use to tackle the disease,” he said.